Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-12-09

Clinical Trial Update: Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients [NA]

View source ↗

Summary

A clinical trial comparing clozapine with amisulpride in treatment-resistant schizophrenia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amisulpride (amisulpride)
  • Clozapine (Clozapine)

Snippet

Sponsor: Geha Mental Health Center | Conditions: Schizophrenia, Treatment Resistant Disorders | NA | Status: WITHDRAWN